BioMarin sets stage early for hemophilia cure off-Broadway

BioMarin Pharmaceutical Inc is turning to the theater to establish its name with hemophilia patients, long before its experimental cure for the bleeding disorder could reach the market.

from Reuters: Top News https://ift.tt/2BnwbDp